PCSK7 and triple-negative breast carcinoma: Our METABRIC data indicated that patients with high PCSK7 and high CASC4 had significantly worse prognosis than those with high CASC4 but low PCSK7. In addition, we demonstrated that endogenous shedding of CASC4 is only observed in triple-negative breast cancer cells MDA-MB-231.